Premium
Unraveling subcutaneous panniculitis‐like T‐cell lymphoma: An association between subcutaneous panniculitis‐like T‐cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis
Author(s) -
LeBlanc Robert E.,
Lansigan Frederick
Publication year - 2021
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.13863
Subject(s) - hemophagocytic lymphohistiocytosis , lymphoma , medicine , panniculitis , hemophagocytosis , lymphoproliferative disorders , pathology , immunology , bone marrow , disease , pancytopenia
Germline HAVCR2 mutations, recently identified in a large subset of patients with subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL), are associated with an increased risk of hemophagocytic lymphohistiocytosis (HLH). Discovery of this heritable HLH/SPTCL diathesis has expanded our understanding of a rare and molecularly heterogeneous lymphoma. Furthermore, patients with SPTCL have excellent survival unless they develop HLH. Therefore, through compiling data on SPTCL‐related conditions that predispose patients to HLH, we are better able to predict which patients with SPTCL have the greatest risk of mortality. We present the first case of SPTCL with concomitant HLH and autoimmune lymphoproliferative syndrome (ALPS) in a patient who was subsequently diagnosed with familial HLH (F‐HLH) attributable to a germline STXBP2 splice‐site mutation. She had wild‐type HAVCR2 . Reports including ours show how SPTCL can evolve in the setting of an exaggerated host inflammatory response attributable to a variety of unusual underlying etiologies.